Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	13.76	60.26	52.97
Graham Fair Price	11.05	55.91	50.34
PEG	0.00	0.00	0.00
Price/Book	22.18	7.83	6.41
Price/Cash Flow	-39.50	-310.73	-222.74
Prices/Earnings	15.17	28.95	25.14
Price/Sales	14.65	16.51	14.40
Price/FCF	-39.50	-310.73	-222.74
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	0.46	0.35	0.34
Operating Margin	5.62	0.15	0.14
ROA	-2.85	0.04	0.04
ROE	0.06	0.07	6.09
ROIC	0.05	0.05	7.91
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	0.00	0.00
EPS QOQ	0.00	0.00	0.00
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	54.40	50.21	-7.70
Days Sales Outstanding (DSO)	33.74	44.19	30.96
Inventory Turnover	1.65	1.79	8.34
Debt/Capitalization	0.25	0.29	12.79
Quick Ratio	0.41	0.50	20.74
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	42.03	45.32	7.81
Cash	2.67	5.43	103.71
Capex	-6.59	-7.73	-17.29
Free Cash Flow	-1.21	-1.14	5.58
Revenue	18.71	21.50	14.89
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	0.77	0.77	-0.74
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.30	2.19	-4.57
Naive Interpretation	Member

06 - Financial Health · Bad

Rating